Sang‐Yeob Kim
- Cancer Research top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 25
- Pancreatic and Hepatic Oncology Research 9
- Immunology top 10%
- Immune cells in cancer 8
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 4
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 4
-
- Nanoplatforms for cancer theranostics 4
-
- Inflammatory Bowel Disease 4
- Co-authors
- Yeon‐Mi RyuSeung‐Jae MyungChan‐Gi PackDae Hyun HaEunju DoJun Ho LeeByong Seung ChoYong Weon Yi
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Nano Letters (1 paper)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Sang‐Yeob Kim
79 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 262
- Oncology 440
- Immunology 271
- Molecular Biology 797
- Pulmonary and Respiratory Medicine 240
Countries citing papers authored by Sang‐Yeob Kim
This map shows the geographic impact of Sang‐Yeob Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang‐Yeob Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang‐Yeob Kim more than expected).
Fields of papers citing papers by Sang‐Yeob Kim
This network shows the impact of papers produced by Sang‐Yeob Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang‐Yeob Kim. The network helps show where Sang‐Yeob Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sang‐Yeob Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitorbreakdown → | 2024 | 81 |
| 3 | 2024 | 11 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 51 | |
| 13 | 2021 | 38 | |
| 14 | 2021 | 14 | |
| 15 | 2020 | 21 | |
| 16 | 2020 | 27 | |
| 17 | 2020 | 84 | |
| 18 | 2019 | 28 | |
| 19 | 2018 | 8 | |
| 20 | 2014 | 16 |
About Sang‐Yeob Kim
Sang‐Yeob Kim is a scholar working on Oncology, Immunology and Transplantation, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Pancreatic and Hepatic Oncology Research (9 papers), Immune cells in cancer (8 papers), Immune Cell Function and Interaction (7 papers), RNA Interference and Gene Delivery (4 papers), Nanoplatforms for cancer theranostics (4 papers), Immunotherapy and Immune Responses (4 papers) and Inflammatory Bowel Disease (4 papers). The work is most often cited by research in Cancer Research (262 citations), Oncology (440 citations) and Immunology (271 citations). Sang‐Yeob Kim has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Yeon‐Mi Ryu, Seung‐Jae Myung, Chan‐Gi Pack, Dae Hyun Ha, Eunju Do, Jun Ho Lee, Byong Seung Cho, Yong Weon Yi, Sung Wook Hwang and Yebin Jung. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.